Breiter Capital Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
$2M Buy
8,272
+642
+8% +$148K 0.99% 33
2021
Q4
$1.72M Buy
7,630
+145
+2% +$30.6K 0.84% 43
2021
Q3
$1.59M Buy
7,485
+313
+4% +$72K 0.91% 41
2021
Q2
$1.75M Buy
+7,172
New +$1.76M 0.94% 34
2021
Q1
Sell
-5,792
Closed -$1.33M 55
2020
Q4
$1.33M Buy
5,792
+449
+8% +$104K 0.93% 34
2020
Q3
$1.36M Sell
5,343
-357
-6% -$88.4K 1.11% 25
2020
Q2
$1.34M Buy
5,700
+94
+2% +$21.4K 1.24% 20
2020
Q1
$1.14M Sell
5,606
-320
-5% -$69.9K 1.34% 18
2019
Q4
$1.43M Sell
5,926
-254
-4% -$56K 1.55% 17
2019
Q3
$1.2M Sell
6,180
-64
-1% -$12.3K 1.57% 16
2019
Q2
$1.15M Buy
6,244
+2,251
+56% +$403K 1.54% 17
2019
Q1
$681K Sell
3,993
-1,916
-32% -$366K 0.91% 35
2018
Q4
$1.15M Buy
5,909
+777
+15% +$152K 2.33% 9
2018
Q3
$1.06M Buy
5,132
+1,056
+26% +$208K 1.35% 20
2018
Q2
$752K Buy
4,076
+83
+2% +$14.7K 1.05% 29
2018
Q1
$681K Buy
3,993
+1,294
+48% +$238K 0.92% 34
2017
Q4
$469K Buy
+2,699
New +$478K 0.67% 53

Other funds holding AMGN

Breiter Capital Management's AMGN Position: Q1 2022 in Review

Breiter Capital Management increased its Amgen (AMGN) stake by 8.4% in Q1 2022, buying an estimated $148K and bringing the position to 8,272 shares worth $2M. The position accounts for 0.99% of the portfolio, ranked #33.

Breiter Capital Management first reported a position in AMGN in Q4 2017 and has held it in 17 quarters since. 2,337 funds tracked by Wall St. Rank hold AMGN as of Q1 2022.

  • Breiter Capital Management held 8,272 shares of Amgen worth $2M as of Q1 2022.
  • Breiter Capital Management bought 642 Amgen shares in Q1 2022, an estimated $148K.
  • Amgen made up 0.99% of Breiter Capital Management's portfolio in Q1 2022, its #33 holding.
  • Breiter Capital Management first reported a position in Amgen in Q4 2017 and has held it in 17 quarters since.
  • 2,337 funds tracked by Wall St. Rank held Amgen as of Q1 2022.

Based on Breiter Capital Management's 13F filing for Q1 2022, filed 11 May 2022.